208 related articles for article (PubMed ID: 34160068)
1. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.
Withrow DR; Devesa SS; Deapen D; Petkov V; Van Dyke AL; Adamo M; Armstrong TS; Gilbert MR; Linet MS
Cancer; 2021 Oct; 127(19):3579-3590. PubMed ID: 34160068
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.
Dolecek TA; Dressler EV; Thakkar JP; Liu M; Al-Qaisi A; Villano JL
Cancer; 2015 Jul; 121(14):2400-10. PubMed ID: 25872752
[TBL] [Abstract][Full Text] [Related]
3. Incidence of vestibular schwannomas in the United States.
Kshettry VR; Hsieh JK; Ostrom QT; Kruchko C; Barnholtz-Sloan JS
J Neurooncol; 2015 Sep; 124(2):223-8. PubMed ID: 26024654
[TBL] [Abstract][Full Text] [Related]
4. Underreporting of Vestibular Schwannoma Incidence Within National Brain Tumor and Cancer Registries in the United States.
Marinelli JP; Nassiri AM; Habermann EB; Lohse CM; Holton SJ; Carlson ML
Otol Neurotol; 2021 Jul; 42(6):e758-e763. PubMed ID: 34111053
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Benign Meningiomas in the United States: Current and Future Trends.
Bhala S; Stewart DR; Kennerley V; Petkov VI; Rosenberg PS; Best AF
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34250440
[TBL] [Abstract][Full Text] [Related]
7. Descriptive Epidemiology of Spinal Meningiomas in the United States.
Kshettry VR; Hsieh JK; Ostrom QT; Kruchko C; Benzel EC; Barnholtz-Sloan JS
Spine (Phila Pa 1976); 2015 Aug; 40(15):E886-9. PubMed ID: 25996535
[TBL] [Abstract][Full Text] [Related]
8. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018.
Recker MJ; Kuo CC; Prasad D; Attwood K; Plunkett RJ
J Neurooncol; 2022 Oct; 160(1):13-22. PubMed ID: 35819682
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of vestibular schwannomas.
Propp JM; McCarthy BJ; Davis FG; Preston-Martin S
Neuro Oncol; 2006 Jan; 8(1):1-11. PubMed ID: 16443943
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Kshettry VR; Ostrom QT; Kruchko C; Al-Mefty O; Barnett GH; Barnholtz-Sloan JS
Neuro Oncol; 2015 Aug; 17(8):1166-73. PubMed ID: 26008603
[TBL] [Abstract][Full Text] [Related]
11. Changes in incidence trends of meningioma in Finland, 1990-2017: analysis of Finnish Cancer Registry data.
Ekqvist O; Raitanen J; Auvinen A
Acta Oncol; 2023 Sep; 62(9):994-1000. PubMed ID: 37669182
[TBL] [Abstract][Full Text] [Related]
12. Trends in intracranial meningioma incidence in the United States, 2004-2015.
Lin DD; Lin JL; Deng XY; Li W; Li DD; Yin B; Lin J; Zhang N; Sheng HS
Cancer Med; 2019 Oct; 8(14):6458-6467. PubMed ID: 31475482
[TBL] [Abstract][Full Text] [Related]
13. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States.
Achey RL; Gittleman H; Schroer J; Khanna V; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2019 Feb; 21(3):380-391. PubMed ID: 30295804
[TBL] [Abstract][Full Text] [Related]
14. Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study.
Schüz J; Steding-Jessen M; Hansen S; Stangerup SE; Cayé-Thomasen P; Poulsen AH; Olsen JH; Johansen C
Am J Epidemiol; 2011 Aug; 174(4):416-22. PubMed ID: 21712479
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of adult meningioma: Report from the Dutch Brain Tumour Registry (2000-2019).
Ho VKY; Anten MM; Garst A; Bos EM; Snijders TJ; Eekers DBP; Seute T;
Eur J Neurol; 2023 Oct; 30(10):3244-3255. PubMed ID: 37433563
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility weighted imaging - a problem-solving tool in differentiation of cerebellopontine angle schwannomas and meningiomas.
Mishra A; Thomas B; Kapilamoorthy TR
Neuroradiol J; 2017 Jun; 30(3):253-258. PubMed ID: 28627983
[TBL] [Abstract][Full Text] [Related]
17. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
[TBL] [Abstract][Full Text] [Related]
19. Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States.
Carlson ML; Glasgow AE; Grossardt BR; Habermann EB; Link MJ
J Neurooncol; 2016 Sep; 129(2):269-79. PubMed ID: 27334903
[TBL] [Abstract][Full Text] [Related]
20. Intracanalicular meningioma mimicking vestibular schwannoma.
Asaoka K; Barrs DM; Sampson JH; McElveen JT; Tucci DL; Fukushima T
AJNR Am J Neuroradiol; 2002 Oct; 23(9):1493-6. PubMed ID: 12372737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
